Uncertainty and Equipoise: At Interplay Between Epistemology, Decision Making and EthicsDJULBEGOVIC, Benjamin.The American journal of the medical sciences (Print). 2011, Vol 342, Num 4, pp 282-289, issn 0002-9629, 8 p.Conference Paper

A data-mining approach to improving Polycythemia Vera diagnosisKANTARDZIC, Mehmed; DJULBEGOVIC, Benjamin; HAMDAN, Hazem et al.Computers & industrial engineering. 2002, Vol 43, Num 4, pp 765-773, issn 0360-8352, 9 p.Article

Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: A meta-analysisLYMAN, Gary H; KUDERER, Nicole M; DJULBEGOVIC, Benjamin et al.The American journal of medicine. 2002, Vol 112, Num 5, pp 406-411, issn 0002-9343Article

Optimal type I and type II error pairs when the available sample size is fixedIOANNIDIS, John P. A; HOZO, Iztok; DJULBEGOVIC, Benjamin et al.Journal of clinical epidemiology. 2013, Vol 66, Num 8, pp 903-910, issn 0895-4356, 8 p.Article

Articulating and responding to uncertainties in clinical research = Exprimer et répondre aux incertitudes de la recherche cliniqueDJULBEGOVIC, Benjamin.The Journal of medicine and philosophy. 2007, Vol 32, Num 2, pp 79-98, issn 0360-5310, 20 p.Article

Thalidomide versus bortezomib based regimens as first-line therapy for patients with multiple myeloma: a systematic reviewKUMAR, Ambuj; HOZO, Iztok; WHEATLEY, Keath et al.American journal of hematology. 2011, Vol 86, Num 1, pp 18-24, issn 0361-8609, 7 p.Article

Systematic review of high dose chemotherapy and autologous haematopoietic stem cell transplantation for chronic lymphocytic leukaemia : what is the published evidence?KHARFAN-DABAJA, Mohamed A; KUMAR, Ambuj; BEHERA, Madhusmita et al.British journal of haematology. 2007, Vol 139, Num 2, pp 234-242, issn 0007-1048, 9 p.Article

Reliable data on 5- and 10-year survival provide accurate estimates of 15-year survival in estrogen receptor-positive early-stage breast cancerHEROLD, Christina I; DJULBEGOVIC, Benjamin; HOZO, Iztok et al.Breast cancer research and treatment. 2010, Vol 121, Num 3, pp 771-776, issn 0167-6806, 6 p.Article

Comparative efficacy of first-line therapies for advanced-stage chronic lymphocytic leukemia: A multiple-treatment meta-analysisTERASAWA, Teruhiko; TRIKALINOS, Nikolaos A; DJULBEGOVIC, Benjamin et al.Cancer treatment reviews. 2013, Vol 39, Num 4, pp 340-349, issn 0305-7372, 10 p.Article

Pharmaceutical industry sponsorship and research outcome and quality: systematic reviewLEXCHIN, Joel; BERO, Lisa A; DJULBEGOVIC, Benjamin et al.BMJ. British medical journal (International ed.). 2003, Vol 326, Num 7400, pp 1167-1170, issn 0959-8146, 4 p.Article

Tandem Versus Single Autologous Hematopoietic Cell Transplantation for the Treatment of Multiple Myeloma : A Systematic Review and Meta-analysisKUMAR, Ambuj; KHARFAN-DABAJA, Mohamed A; GLASMACHER, Axel et al.Journal of the National Cancer Institute. 2009, Vol 101, Num 2, pp 100-106, issn 0027-8874, 7 p.Article

Treatment tolerance and efficacy in geriatric oncology : A systematic review of phase III randomized trials conducted by five national cancer institute-sponsored cooperative groupsKUMAR, Ambuj; SCARES, Heloisa P; BALDUCCI, Lodovico et al.Journal of clinical oncology. 2007, Vol 25, Num 10, pp 1272-1276, issn 0732-183X, 5 p.Article

Decision-Making When Data and Inferences Are Not Conclusive : Risk-Benefit and Acceptable Regret ApproachHOZO, Iztok; SCHELL, Michael J; DJULBEGOVIC, Benjamin et al.Seminars in hematology. 2008, Vol 45, Num 3, pp 150-159, issn 0037-1963, 10 p.Article

Published methodological quality of randomized controlled trials does not reflect the actual quality assessed in protocolsMHASKAR, Rahul; DJULBEGOVIC, Benjamin; MAGAZIN, Anja et al.Journal of clinical epidemiology. 2012, Vol 65, Num 6, pp 602-609, issn 0895-4356, 8 p.Article

Colony-Stimulating Factors for Febrile Neutropenia during Cancer TherapyBENNETT, Charles L; DJULBEGOVIC, Benjamin; NORRIS, Leann B et al.The New England journal of medicine. 2013, Vol 368, Num 12, pp 1131-1139, issn 0028-4793, 9 p.Article

Optimal information size in trial sequential analysis of time-to-event outcomes reveals potentially inconclusive results because of the risk of random errorMILADINOVIC, Branko; MHASKAR, Rahul; HOZO, Iztok et al.Journal of clinical epidemiology. 2013, Vol 66, Num 6, pp 654-659, issn 0895-4356, 6 p.Article

Evaluation of serious Adverse Drug reactions: A Proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturersBENNETT, Charles L; NEBEKER, Jonathan R; ANGELOTTA, Cara et al.Archives of internal medicine (1960). 2007, Vol 167, Num 10, pp 1041-1049, issn 0003-9926, 9 p.Article

Colony-stimulating factors for chemotherapy-induced febrile neutropenia : A meta-analysis of randomized controlled trialsCLARK, Otavio A. C; LYMAN, Gary H; CASTRO, Aldemar A et al.Journal of clinical oncology. 2005, Vol 23, Num 18, pp 4198-4214, issn 0732-183X, 17 p.Article

Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABBCARSON, Jeffrey L; GROSSMAN, Brenda J; RAO, Sunil V et al.Annals of internal medicine. 2012, Vol 157, Num 1, pp 49-58, issn 0003-4819, 10 p.Article

Quality of Reporting of Serious Adverse Drug Events to an Institutional Review Board: A Case Study with the Novel Cancer Agent, lmatinib MesylateDORR, David A; BURDON, Rachel; BOYLE, Simone et al.Clinical cancer research (Print). 2009, Vol 15, Num 11, pp 3850-3855, issn 1078-0432, 6 p.Article

Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology GroupKUMAR, Ambuj; SOARES, Heloisa; WELLS, Robert et al.BMJ. British medical journal (International ed.). 2005, Vol 331, Num 7528, pp 1295-1298, issn 0959-8146, 4 p.Article

World Health Organization recommendations are often strong based on low confidence in effect estimatesALEXANDER, Paul E; BERO, Lisa; MONTORI, Victor M et al.Journal of clinical epidemiology. 2014, Vol 67, Num 6, pp 629-634, issn 0895-4356, 6 p.Article

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer : a meta-analysis of randomised trialsBOHLIUS, Julia; SCHMIDLIN, Kurt; PIPER, Margaret et al.Lancet (British edition). 2009, Vol 373, Num 9674, pp 1532-1542, issn 0140-6736, 11 p.Article

Misconceptions, Challenges, Uncertainty, and Progress in Guideline RecommendationsKUNZ, Regina; DJULBEGOVIC, Benjamin; SCHUNEMANN, Holger J et al.Seminars in hematology. 2008, Vol 45, Num 3, pp 167-175, issn 0037-1963, 9 p.Article

Evaluation of new treatments in radiation oncology: Are they better than standard treatments?SOARES, Heloisa P; KUMAR, Ambuj; DJULBEGOVIC, Benjamin et al.JAMA, the journal of the American Medical Association. 2005, Vol 293, Num 8, pp 970-978, issn 0098-7484, 9 p.Article